NCT00563355View on ClinicalTrials.gov

A Study to Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease Patients

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

February 28, 2001

Study Completion Date

November 30, 2003

Conditions
Chronic DiseaseKidney DiseasesCardiovascular Diseases
Interventions
DRUG

erythropoietin

Trial Locations (1)

Unknown

Prince of Wales Hospital, Hong Kong

All Listed Sponsors
collaborator

The Hong Kong Society of Nephrology

OTHER

lead

Hospital Authority, Hong Kong

OTHER_GOV

NCT00563355 - A Study to Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease Patients | Biotech Hunter | Biotech Hunter